Detalles de la búsqueda
1.
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials.
Lancet Oncol
; 24(7): 783-797, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37414011
2.
Implications of analysing time-to-event outcomes as binary in meta-analysis: empirical evidence from the Cochrane Database of Systematic Reviews.
BMC Med Res Methodol
; 22(1): 73, 2022 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35307005
3.
A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trials.
PLoS Med
; 18(5): e1003629, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33956789
4.
Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.
Lancet
; 396(10260): 1422-1431, 2020 10 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33002431
5.
Comparison of aggregate and individual participant data approaches to meta-analysis of randomised trials: An observational study.
PLoS Med
; 17(1): e1003019, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32004320
6.
Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data.
Lancet Oncol
; 17(2): 243-256, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26718929
7.
Individual Participant Data (IPD) Meta-analyses of Randomised Controlled Trials: Guidance on Their Use.
PLoS Med
; 12(7): e1001855, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26196287
8.
Meta-analysis of time-to-event outcomes from randomized trials using restricted mean survival time: application to individual participant data.
Stat Med
; 34(21): 2881-98, 2015 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26099573
9.
Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.
JAMA
; 313(16): 1657-65, 2015 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-25919529
10.
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data.
Lancet Oncol
; 14(7): 619-26, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23680111
11.
Use of multiple covariates in assessing treatment-effect modifiers: A methodological review of individual participant data meta-analyses.
Res Synth Methods
; 15(1): 107-116, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37771175
12.
Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer.
J Clin Oncol
; 42(9): 1044-1054, 2024 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181323
13.
Estimating interactions and subgroup-specific treatment effects in meta-analysis without aggregation bias: A within-trial framework.
Res Synth Methods
; 14(1): 68-78, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35833636
14.
Using individual participant data to improve network meta-analysis projects.
BMJ Evid Based Med
; 28(3): 197-203, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35948411
15.
Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials.
Lancet Neurol
; 22(12): 1140-1149, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37839434
16.
Sharing individual participant data: through a systematic reviewer lens.
Trials
; 23(1): 167, 2022 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35189931
17.
Duplicated network meta-analysis in advanced prostate cancer: a case study and recommendations for change.
Syst Rev
; 11(1): 274, 2022 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36527153
18.
Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation.
Health Technol Assess
; 26(4): 1-128, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35076012
19.
Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis.
PLoS One
; 17(7): e0270668, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35802687
20.
Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics.
BMC Med Res Methodol
; 11: 41, 2011 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-21473747